Omega Diagnostics Group (ODX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.40p
   
  • Change Today:
      0.000p
  • 52 Week High: 10.73
  • 52 Week Low: 2.30
  • Currency: UK Pounds
  • Shares Issued: 327.69m
  • Volume: 183,921
  • Market Cap: 11.14m
  • Beta: 0.02

ODX Overview

Our mission is to improve human health and well-being through innovative diagnostic tests and global partnerships. Omega is focused on providing specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within Health & Wellbeing and Global Health.

1 Day Chart (06-02-2023)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -10.9% -26.7%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 1.3 1.5
Pr/Book 0.9  
Latest F'cast
Revenue 25.2% -12.2%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ODX Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-18 13.55 (6.91) (0.37)p n/a n/a n/a n/a 0.0%
31-Mar-19 9.76 1.18 (0.09)p n/a n/a n/a n/a 0.0%
31-Mar-20 9.82 (8.30) (0.19)p n/a n/a n/a n/a 0.0%
31-Mar-21 6.82 (0.55) 0.38p 201.3 n/a n/a n/a 0.0%
31-Mar-22 8.54 (0.95) (0.40)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ODX Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-23 7.50 (2.00) (0.90)p n/a n/a n/a n/a 0.0%
31-Mar-24 11.00 (0.70) (0.30)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

ODX Company Announcements

Holding(s) in Company 27-Jan-2023 15:03 RNS
Director/PDMR Shareholding 27-Jan-2023 09:36 RNS
Trading update 18-Jan-2023 07:00 RNS

Latest ODX Director Deals

Traded Action Notifier PriceAmountValue
26-Jan-23 Buy Jag Grewal 3.48p 1,000,000 34,839.00
26-Jan-23 Buy Christopher Paul Lea 3.48p 1,000,000 34,839.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ODX Market Data

Currency UK Pounds
Share Price 3.40p
Change Today 0.000p
% Change 0.00 %
52 Week High 10.73
52 Week Low 2.30
Volume 183,921
Shares Issued 327.69m
Market Cap 11.14m
Beta 0.02

ODX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.40% above the market average5.40% above the market average5.40% above the market average5.40% above the market average5.40% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average
Price Trend
56.31% below the market average56.31% below the market average56.31% below the market average56.31% below the market average56.31% below the market average
58.97% below the sector average58.97% below the sector average58.97% below the sector average58.97% below the sector average58.97% below the sector average
Income Not Available
Growth
22.52% below the market average22.52% below the market average22.52% below the market average22.52% below the market average22.52% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

ODX Dividends

No dividends found

Trades for 06-Feb-2023

Time Volume / Share Price
15:15 2,309 @ 3.36p
14:52 3,250 @ 3.42p
14:31 14,890 @ 3.36p
12:05 10,000 @ 3.42p
11:43 10,817 @ 3.36p

ODX Key Personnel

CEO Jag Grewal
Chair Simon Gordon Douglas
CFO Christopher Paul Lea

Top of Page